|
Three Months Ended
|
||||||||
|
January 29,
2023
|
January 30,
2022
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
28,950
|
$
|
31,726
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
19,105
|
20,810
|
||||||
|
Share-based compensation
|
1,821
|
1,457
|
||||||
|
Changes in operating assets, liabilities and other
|
(22,196
|
)
|
5,137
|
|||||
|
Net cash provided by operating activities
|
27,680
|
59,130
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property, plant and equipment
|
(31,097
|
)
|
(19,175
|
)
|
||||
|
Government incentives
|
1,014
|
-
|
||||||
|
Other
|
(87
|
)
|
(43
|
)
|
||||
|
Net cash used in investing activities
|
(30,170
|
)
|
(19,218
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Repayments of debt
|
(9,218
|
)
|
(15,192
|
)
|
||||
|
Purchases of treasury stock
|
-
|
(2,522
|
)
|
|||||
|
Contributions from noncontrolling interest
|
-
|
14,997
|
||||||
|
Proceeds from share-based arrangements
|
672
|
3,840
|
||||||
|
Net settlements of restricted stock awards
|
(1,168
|
)
|
(1,458
|
)
|
||||
|
Net cash used in financing activities
|
(9,714
|
)
|
(335
|
)
|
||||
|
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
27,499
|
(2,057
|
)
|
|||||
|
Net increase in cash, cash equivalents, and restricted cash
|
15,295
|
37,520
|
||||||
|
Cash, cash equivalents, and restricted cash, beginning of period
|
322,409
|
279,680
|
||||||
|
Cash, cash equivalents, and restricted cash, end of period
|
$
|
337,704
|
$
|
317,200
|
||||